The independent platform for news, articles and advice for professionals in laboratory medicine

Reference range review for the RSR acetylcholine receptor antibody assay

Establishing optimal cut-off values is essential in ensuring excellent results accuracy and quality, a prime example being in facilitating the diagnosis of myasthenia gravis and its appropriate treatment. Here, Rebecca Cottage and colleagues from Manchester report on measures undertaken to check and amend the reference range for anti-acetylcholine receptor antibodies.

Myasthenia gravis (MG) is the most common autoimmune condition to affect the neuromuscular junction, and is characterised by progressive skeletal muscle weakness and fatiguability. Detection of anti-acetylcholine receptor (AChR) antibodies is frequently used as a first-line investigation for MG. The authors’ laboratory currently uses the RSR enzyme-linked immunosorbent assay (ELISA) kit for this test, with a quoted manufacturer’s cut-off value of 0.45 nmol/L. 

Initial verification of the assay with healthy blood donor sera indicated that the manufacturer’s cut-off value may be too low, with further observations from routine testing showing a high incidence of low-positive results. These findings plus a recent UK NEQAS non-conformity has prompted a review and revision of the established cut-off. 

Anti-AChR values were obtained from a cohort of 29 neurology and 11 ophthalmology patients with established MG. Here, the authors describe the use of Receiver Operator Curve (ROC) analysis to establish a new optimal cut-off value for the assay. As detailed in this article, preliminary analysis implies that the specificity is much improved, the new cut-off is more clinically relevant, in line with published data, and should not lead to further external quality assessment (EQA) misclassifications.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.
Register

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025